Publications

Publications

Filter Results: (187) Arrow Down

Show Results For

← Page 8 of 187 Results →
Sort by

Are you looking for?

→Search All HBS Web
  • June 2005 (Revised July 2006)
  • Background Note

Note on the Convergence Between Genomics & Information Technology

By: David B. Yoffie, Dharmesh M Mehta and Rachel Sha
Focuses on the convergence between the genomics and semiconductor industries, in particular organ printing, DNA computing, biomolecular sensory networks, and DNA microarrays. Explains what this newly converged world looks like based on current research and findings in... View Details
Keywords: Genetics; Information Technology; Business Model; Disruptive Innovation; Biotechnology Industry; Information Technology Industry; Semiconductor Industry; Medical Devices and Supplies Industry
Related
  • 11 Jan 2017
  • Research & Ideas

The Paradoxical Quest to Make Food Look 'Natural' With Artificial Dyes

eat green grass, which is rich in the orange pigment beta-carotene. The pigment colors the fat in the cows’ milk, which gives the butter a golden color. But, in winter, cows don’t eat grass. Rather, they eat grain, which, unless it has been View Details
Keywords: by Carmen Nobel
  • April 2008
  • Teaching Note

Viagen: Revolutioning the Livestock Industry (TN)

By: David E. Bell, Mary L. Shelman and Eliot Sherman
Teaching Note for [507021]. View Details
Keywords: Investment; Genetics; Production; Training; Customers; Supply Chain; Business Plan; Commercialization; Information Technology; Performance Efficiency; Governing Rules, Regulations, and Reforms; Industry Structures; Agriculture and Agribusiness Industry; Biotechnology Industry
Related
  • 23 Mar 2016
  • Research & Ideas

Researchers Prove C-Suite Gender Gap—but Can’t Explain It

that male and female executives sharing equal attributes neither have the same probability of reaching the top, nor are they paid equally” The worse news is there doesn’t seem to be much women can do to close that gap—no matter how talented, educated, skilled, lucky,... View Details
Keywords: by Carmen Nobel
  • 07 Aug 2006
  • Research & Ideas

Whatever Happened to Caveat Emptor?

the center of global trade disputes. World Trade Organization (WTO) disputes between Europe and the United States over hormone-treated beef and genetically modified crops evoke how difficult it can be to reconcile different consumer... View Details
Keywords: by Sean Silverthorne; Retail
  • 02 Jul 2001
  • Research & Ideas

Ray A. Goldberg

issues," he beams, "from land reform in Mexico to the development of the genetically modified tomato." "The genetic research revolution is changing our global economy and society more... View Details
Keywords: by Staff; Agriculture & Agribusiness
  • 17 Mar 2022
  • Research & Ideas

Navigating Tradeoffs: How Purpose Becomes a Company's ‘Lighthouse in the Storm’

genetically modified corn to manufacture it, and only consumers in locations with municipal composting facilities could compost this packaging. Most of the company’s compostable plastic would wind up in landfills, or even worse, consumers... View Details
Keywords: by Ranjay Gulati
  • 07 Nov 2017
  • First Look

New Research and Ideas: November 7, 2017

for its commitment to improving health care outcomes and lowering costs by reducing treatment variation, made the surprising decision to invest significant resources in an innovative precision medicine unit, which would provide life-extending, View Details
Keywords: Carmen Nobel
  • 15 Jul 2008
  • First Look

First Look: July 15, 2008

institute, The Broad Institute. The culture of the Broad centered on science, and those involved considered it to be at the edge of the scientific frontier. In just four years the Broad had made many important scientific contributions to the biomedical field. These... View Details
Keywords: Martha Lagace
  • June 1997 (Revised September 1997)
  • Case

Genset Initial Public Offering (B)

By: Paul A. Gompers and Jeffrey M. Anapolsky
Supplements the (A) case. View Details
Keywords: Business Model; Initial Public Offering; Genetics; Going Public; Management Teams; Biotechnology Industry; France; United States
Related
  • June 1997 (Revised March 2001)
  • Case

Genset Initial Public Offering (A)

By: Paul A. Gompers and Jeffrey M. Anapolsky
Pascal Brandys, founder and CEO of Genset, must decide whether to take this young biotechnology company public. If so, should he do a dual offering in both France and the U.S.? The case also explores the business models in genomics research. View Details
Keywords: Business Model; Initial Public Offering; Genetics; Going Public; Management Teams; Biotechnology Industry; France; United States
Related
  • 07 Apr 2003
  • Research & Ideas

Three Steps for Crisis Prevention

genetically modified foods in Europe. Betting the company on a "life sciences" vision, Shapiro had sold or spun off Monsanto's traditional chemical businesses and moved aggressively to acquire seed companies. Dazzled by the... View Details
Keywords: by Michael D. Watkins & Max H. Bazerman
  • September 2019 (Revised August 2020)
  • Case

Engineering an Inclusive Bioeconomy

By: Tarun Khanna, Raffaella Sadun and Susie L. Ma
In 2019, entrepreneur Juan Carlos Castilla-Rubio was developing a project he hoped could generate and share wealth from the natural resources of the Amazon without destroying those resources. His idea, called Earth Bank of Codes (EBC), would create a library of the... View Details
Keywords: Decision Making; Development Economics; Entrepreneurship; Innovation and Invention; Intellectual Property; Emerging Markets; Market Design; Marketplace Matching; Science; Genetics; Natural Environment; Environmental Sustainability; Climate Change; Social Enterprise; Strategy; Strategic Planning; Information Technology; Ownership; Social Psychology; Trust; Society; Biotechnology Industry; South America; Amazon Basin
Related
  • 07 Oct 2014
  • First Look

First Look: October 7

money for these purposes. In 2014, the MMRF was in the midst of its CoMMpass program; a multi-year effort to collect tissue samples from 1,000 patients at key junctures in their disease, sequence these samples to better understand the View Details
Keywords: Sean Silverthorne
  • 12 Nov 2015
  • Research & Ideas

Can Consumers be Trusted with Their Own Health Care?

reveals a person’s genetically based health risk across dozens of disease categories. 23andMe test results showed one patient at higher risk of liver and bowel cancer—and that made sense, given family history. The patient  discussed the... View Details
Keywords: by Dina Gerdeman; Health
  • 05 Dec 2013
  • Op-Ed

Encourage Breakthrough Health Care by Competing on Products Rather Than Patents

Like many people interested in the tangled connections between health care progress and intellectual property rights, I avidly followed the Myriad Genetics case, decided by the Supreme Court this June 13. In sum, molecular diagnostics... View Details
Keywords: by Richard G. Hamermesh; Biotechnology; Health
  • 25 Apr 2005
  • Research & Ideas

New Learning at American Home Products

commercializing new biotechnology. This lack of technical capabilities led to two major acquisitions late in the twentieth century. In 1989 American Home Products acquired, for $666 million, 60 percent of the equity of the Genetics... View Details
Keywords: by Alfred D. Chandler Jr.; Chemical; Health; Manufacturing; Pharmaceutical
  • 13 May 2014
  • First Look

First Look: May 13

large cadre of data scientists who could develop and run programs to sift through the mountains of genetic data that were being generated every day. But the approach raised other questions. Could people trained in traditional fields of... View Details
Keywords: Sean Silverthorne
  • 25 Feb 2014
  • First Look

First Look: February 25

is based in Massachusetts and lists in London on AIM. Products are genetically modified fast-growing salmon for fish farmers and disease-prevention drugs and diagnostic kits for farmed shrimp. Purchase this case:... View Details
Keywords: Sean Silverthorne
  • 26 Sep 2006
  • First Look

First Look: September 26, 2006

share in the billion dollar DNA-synthesis market. Codon had several distinctive features for a company its size and age: it was already generating revenue from several different types of customer for its genetic products; it looked... View Details
Keywords: Sean Silverthorne

Are you looking for?

→Search All HBS Web